AP NEWS

The Global Bioinformatics Market by Technology, Application, End-user and Geography - Growth, Trends and Forecast (2018-2023) - ResearchAndMarkets.com

December 7, 2018

DUBLIN--(BUSINESS WIRE)--Dec 7, 2018--The “Bioinformatics Market - Segmented by Technology, Application, End user, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global bioinformatics market is expected to register a CAGR of 19.8% during 2018-2023 (the forecast period).

Growth in Proteomics and Genomics

With the completion of the Human Genome Project (in 2001) and the Human Proteome Project, a vast amount of data has generated, which has given a new dimension to the profiling of proteomic and genomic analyses. The data generated, out of these projects, has driven the growth of the global bioinformatics market, due to the growing demand for tools and platforms for data management, data retrieval, sequence alignment, structure prediction, and other bioinformatics applications.

Other factors driving the market include increasing government spending and rise in R&D initiatives.

Rising Data Complexity Concerns

A large amount of genomic and proteomic data, generated through various sequencing and structure prediction methods, are highly complex. The complexity of the generated data ranges from missing values to excess unwanted information. Data dissemination has been a major challenge for the growth of the bioinformatics market.

Reimbursement hurdles for the manufacturer and high-capital investment are also restraining the market growth.

Developments in the Market

Thermo Fisher Scientific introduced Ion GeneStudio S5 Series, a line of highly versatile next generation sequencers. Biomillenia collaborated with QIAGEN for the use of QIAGEN’s Microbial Genomics Pro Suite, in order to generate next-generation sequence data on microbes identified using Biomillenia’s proprietary microbiome-on-a-chip technology. Agilent Technologies and Eurofins Genomics collaborated to expand SureVector cloning system PerkinElmer had a strategic collaboration with Attivio to launch a new solution in the PerkinElmer Signals™ data discovery platform.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Major Players

Illumina Inc. Life Technologies (Thermo Fischer Scientific) Qiagen N.V. Agilent Technologies PerkinElmer ABM Accelrys Inc. Geneva Bioinformatics S.A. Ontoforce Data4Cure Life Map Sciences (Biotime)

10. Future Market Outlook

For more information about this report visit https://www.researchandmarkets.com/research/g6qp7p/the_global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005470/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Bioinformatics

KEYWORD:

INDUSTRY KEYWORD: RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/07/2018 01:59 PM/DISC: 12/07/2018 01:59 PM

http://www.businesswire.com/news/home/20181207005470/en

AP RADIO
Update hourly